Navigation Links
GADA Points to Safety of FDA Approved Generics in Wake of Wellington Polo Horse Deaths from Compounded Drugs
Date:5/6/2009

WASHINGTON, May 6 /PRNewswire/ -- The Generic Animal Drug Alliance (GADA), an independent professional trade organization representing generic animal health industry interests, says that the recent tragic deaths of 21 horses in Wellington, Florida illustrates the potential safety issues surrounding compounded drugs and reinforces the need for, and value of, Food and Drug Administration (FDA) approved animal generic drugs.

The polo horse deaths were reportedly caused by improperly compounded drugs. Compounded drugs are customized medications prepared by a pharmacist under prescription by a veterinarian. Considered a last resort, compounded drugs should be used only when no FDA-approved animal or human drug is available to treat the animal. Unlike generic drugs, compounded drugs are not FDA-approved and do not follow current good manufacturing practice (cGMP) requirements.

GADA has been working to help veterinarians understand the difference between compounded drugs and generic drugs. Generic drugs, widely used and trusted by veterinarians, are FDA-approved bio-equivalent versions of branded medicines, manufactured under strict regulatory guidelines. Generic drugs, as with other FDA-approved drugs, undergo rigorous testing to meet quality standards. Stephanie Batliner, GADA Chairperson, says that veterinarians face a variety of prescribing options and must be aware of the safety issues. "While generic drugs meet safety standards ensured by FDA-approval, compounded drugs have inherent risks associated with uncontrolled, extemporaneous preparation," says Batliner. GADA provides further information on their website, as well as a link to the brochure "Veterinary Compounding" co-authored by the American Veterinary Medical Association (AVMA), the Animal Health Institute (AHI), and the American Veterinary Distributors Association (AVDA), www.gadaonline.org.

About Generic Animal Drug Alliance

The Generic Animal Drug Alliance (GADA) is an independent professional trade organization that represents the interests of generic animal health companies before Federal regulatory agencies and Congress. Member companies are focused on the development, approval and marketing of high quality generic drugs for animals and pets--making the cost of care for all animals affordable for ranchers, farmers and pet owners.


'/>"/>
SOURCE The Generic Animal Drug Alliance
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The Candies Foundation Appoints Bristol Palin As Teen Ambassador
2. WuXi PharmaTech Appoints Hao Zhou as Vice President of Finance
3. Shamir Optical Industry Ltd. Appoints Amos Netzer as New Chief Executive Officer
4. Protein Sciences Corporation Appoints New Board of Directors
5. China Pharma Holdings, Inc. Appoints Chief Financial Officer and Board Member
6. Mother-daughter breast density study points way to earlier cancer risk assessment
7. PDL BioPharma Appoints Karen J. Wilson as Vice President, Finance and Principal Accounting Officer
8. Craneware Appoints New Non-Executive Director
9. BMP Sunstone Appoints Les R. Baledge to Board of Directors
10. ATS Medical Appoints New Vice President of Marketing
11. InfuSystem Appoints Bryan Russo as Chief Commercial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... A Northwestern Pennsylvania ... domain address. Alpine Springs Rehabilitation & Recovery Center’s new website can be found ... along with its redesigned and retooled website. The treatment center has also revamped ...
(Date:1/23/2017)... ... 2017 , ... Ultimate Medical Academy today announced the keynote ... March 23-25, 2017 in Tampa, and reminded educators and education leaders to submit ... Dr. Michelle R. Weise, executive director of the Sandbox Collaborative, the R&D arm ...
(Date:1/23/2017)... ... ... and plastic balance boards have been around since at least the 1950s and are a ... first and only balance board to use a patent-pending design featuring high-pressure inflation technology and ... as well as skill-level adjustable for all ages and abilities. The board can be ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... the premiere organization in North America for the scientific development, healthcare training and ... Annual Scientific Session, and its 2017 AAT Member Certification Qualification Courses for Technicians, ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... However, choosing the right method is paramount to success. Selecting an inappropriate measurement ... situations where multiple persons use the same equipment. Rare or expensive substances are ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... New York , January 23, 2017 ... Non-Invasive Prenatal Testing Market was valued at US$0.53 bn in ... expanding at a strong 17.50% CAGR between 2014 and 2022. The ... Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 ... Non-invasive ...
(Date:1/23/2017)... The global  anxiety disorders and depression treatment market  is ... incidence of depression worldwide is anticipated to drive the market growth in the ... demand for antidepressants in the recent years. Continue ... ... ...
(Date:1/23/2017)... SAN DIEGO , 23. Januar 2017  ResMed ... China ) und 3B Medical ( Winter ... sich auf eine Vereinbarung über die Beilegung aller globalen ... ist der Verkauf ihrer bestehenden Produkte im ... eine einmalige Zahlung an 3B leisten, um das in ...
Breaking Medicine Technology: